HURLEY MEDICAL CENTER
1. Target Overview & Investment Thesis
HURLEY MEDICAL CENTER is a 369-bed suburban community hospital in GENESEE, MI with $391.6M in net patient revenue and a -26.8% operating margin. The hospital serves a payer mix of 15.6% Medicare, 4.9% Medicaid, and 79.5% commercial.
Thesis: Undervalued. Our ML models identify $28.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -26.8% to -19.4% (+736bps).
| Net Revenue HCRIS | $391.6M |
| Current EBITDA COMPUTED | $-105.0M |
| Operating Margin COMPUTED | -26.8% |
| Occupancy HCRIS | 64.7% |
| Revenue / Bed COMPUTED | $1.1M |
| Net-to-Gross HCRIS | 26.3% |
| Distress Probability ML | 45.1% |
2. Market Context & Competitive Position
MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of -26.8% places it below the state median. Among 40 size-comparable peers (184-738 beds), the median margin is -7.2%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (184-738), prioritizing same-state peers. 40 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HURLEY MEDICAL CENTER (Target) | MI | 369 | $391.6M | -26.8% |
| HENRY FORD HOSPITAL | MI | 670 | $2.32B | -14.8% |
| BRONSON METHODIST HOSPITAL | MI | 439 | $1.06B | -1.4% |
| TRINITY HEALTH ANN ARBOR | MI | 475 | $1.00B | -1.0% |
| EDWARD W. SPARROW HOSPITAL | MI | 425 | $936.1M | -24.5% |
| ASCENSION ST JOHN HOSPITAL | MI | 556 | $929.1M | -9.6% |
| ASCENSION PROVIDENCE HOSPITAL | MI | 527 | $849.3M | -6.5% |
| WILLIAM BEAUMONT HOSPITAL - TR | MI | 484 | $747.4M | 2.3% |
| MUNSON MEDICAL CENTER | MI | 401 | $710.9M | -7.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $28.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $8.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $7.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $7.8M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $4.8M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $251K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-105.0M |
| + RCM Uplift | +$28.8M |
| Pro Forma EBITDA | $-76.1M |
| Current Margin | -26.8% |
| Pro Forma Margin | -19.4% |
| WC Released (1x) | $15.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-161.5M | $-404.2M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-161.5M | $-497.0M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-145.3M | $-454.3M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-145.3M | $-538.6M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-177.6M | $-495.8M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-177.6M | $-603.1M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 40 hospitals with 184-738 beds
- Same-state prioritization (n=41)
- Comp margins: P25=-11.6% / P50=-7.2% / P75=-1.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.